leadf
logo-loader
NASDAQ:SGEN

Seattle Genetics, Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$28.42 billion
Price
156.21 USD
Change
1.72%
52 weeks high
213.92
52 weeks low
133.21

In brief

Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.